Thane Wettig, CEO at KYNTRA BIO, INC. (KYNB), bought 2,800 shares at $7.09 ($20K) on 2026-05-14, disclosed to the SEC on 2026-05-18.
Scheduled purchase ($20k) by CEO.
Something here stands out, but not much.
| Filing → |
| FGEN | BUY | 2024-03-11 | $96K | — | Filing → |
| FGEN | SELL | 2023-06-26 | $13K | — | Filing → |
| FGEN | SELL | 2023-06-22 | $30K | — | Filing → |